Validation of Non-invasive Monitoring of Blood Pressure and Cardiac Output in Healthy Pregnant Women During Cesarean Section
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hemodynamic Changes in Pregnancy
- Sponsor
- Oslo University Hospital
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Systolic blood pressure
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Blood pressure and cardiac output can be measured invasively in pregnant women. Non-invasive monitoring devices are desirable, but until now, no equipment has proven validity. This study aims at validating the non-invasive monitoring device NexFin (second generation Finometer) in pregnant women.
Detailed Description
Validation will be a direct beat-to-beat comparison of data from NexFin and the invasive measurements of blood pressure and calibrated cardiac output as an integrated part of LiDCO Plus. Both comparison of absolute values and the two different devices trending abilities will be analyzed.
Investigators
Leiv Arne Rosseland
Head for R&D department
Oslo University Hospital
Eligibility Criteria
Inclusion Criteria
- •Healthy singleton pregnancies at term scheduled for cesarean delivery
Exclusion Criteria
- •Twins, or multiple gestation, pre-eclampsia, gestational hypertension
- •Reynaud phenomenon
Outcomes
Primary Outcomes
Systolic blood pressure
Time Frame: 15 minutes
Comparison of beat-to-beat data
Secondary Outcomes
- Cardiac output(15 minutes)